IL10 and depressive symptom measurement: Finally, as expected based on a cytokine perspective of the disorder, depression during IFN-α treatment was most likely to be instigated among those individuals with the highest baseline levels of soluble IL-2 receptor (sIL-2r), IL-6, and IL-10 (Wichers et al., 2006).